5 results

• Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026

  December 2, 2025

  Irvin Jackson

  A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman's wrongful death lawsuit.

• Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits

  November 17, 2025

  Irvin Jackson

  Following what it says are promising clinical trial results, Sanofi is seeking yet another approved use for Dupixent, even as concerns grow over the drug's potential link to T-cell lymphoma.

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis

  October 2, 2025

  Irvin Jackson

  A Dupixent lawsuit blames the atopic dermatitis drug for causing a woman to develop a deadly form of cancer, which caused her death.